Medtronic Neurovascular Clinical Affairs
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Medtronic Neurovascular Clinical Affairs sits in the top decile of US sponsors by registered trial count (#743 of 15,742 sponsors by registered trial count).
Medtronic Neurovascular Clinical Affairs: 20 sponsored US clinical trials, 3 recruiting.
Medtronic Neurovascular Clinical Affairs sponsors 20 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 13 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Intracranial Aneurysm, with 3 trials.
Top-decile sponsor footprint
Medtronic Neurovascular Clinical Affairs ranks in the top decile of sponsors by registered trial count (#743 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
13 of 16 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
20 total, page 1 of 1
REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)
NCT07599904
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
NCT06604884
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
NCT02998229
INSPIRE Pipeline™ Shield Post Approval Study
NCT05071963
EvaLuate EndoVascular Treatment of Acutely Ruptured Shallow Intradural Aneurysms With the Pipeline™ Flex Embolization Device With Shield TEchnology™ (ELEVATE)
NCT04391803
Flow Arrest Safety and Technical Success With Balloon Guide Catheters
NCT04416659
Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma
NCT04402632
Pipeline™ Vantage Embolization Device With Shield Technology™ for Wide-Necked Intracranial Aneurysms (ADVANCE)
NCT03873714
Apollo™ Onyx™ Delivery Microcatheter Post Market Safety Study
NCT02378883
Reverse Medical Barrel™ Device for Adjunctive Treatment for Wide-Neck, Intracranial, Bifurcating/Branching Aneurysms
NCT02179190
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
NCT02239640
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
NCT02186561
Solitaire™ With the Intention For Thrombectomy as PRIMary Endovascular Treatment (SWIFT PRIME) Trial
NCT01657461
Aneurysm Study of Pipeline in an Observational Registry
NCT01557036
International Retrospective Study of Pipeline Embolization Device
NCT01558102
Axium™ MicroFX™ for Endovascular Repair of IntraCranial Aneurysm-A Multicenter Study
NCT01323439
SOLITAIRE™ FR With the Intention For Thrombectomy (SWIFT) Study
NCT01054560
Pipeline for Uncoilable or Failed Aneurysms
NCT00777088
Researching AXIUM Coiling Experience and Recanalization (RACER)
NCT00703794
Study Comparing Onyx and TRUFILL in Brain Arteriovenous Malformations (AVMs)
NCT00857662
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Therapeutic Areas
What is open in the Medtronic Neurovascular Clinical Affairs pipeline
3 recruiting of 20 indexed (15% open); 13 completed (65%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Intracranial Aneurysm (3 trials), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medtronic Neurovascular Clinical Affairs: open-pipeline peers nationwide
Peers matched on 20 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Medtronic Neurovascular Clinical Affairs sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 20 trials (± recruiting share)
- 59th Medical Wing · 20 trials · 15% recruiting
- Abiomed · 20 trials · 10% recruiting
- Agency for Healthcare Research and Quality (AHRQ) · 20 trials · 0% recruiting
- Alliance Foundation Trials · 20 trials · 15% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Hoag Memorial Hospital Presbyterian · 15% recruiting · 20 trials
- Vivek Reddy · 15% recruiting · 20 trials
- Georgetown University · 15% recruiting · 227 trials
- Arizona State University · 15% recruiting · 187 trials
Related
What to do with this Medtronic Neurovascular Clinical Affairs page
20 registered trials is a research-attention snapshot, not an endorsement of Medtronic Neurovascular Clinical Affairs or any single study.
- 3 of Medtronic Neurovascular Clinical Affairs's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Intracranial Aneurysm is the condition Medtronic Neurovascular Clinical Affairs studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Intracranial Aneurysm trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Medtronic Neurovascular Clinical Affairs pipeline card: 20 registered trials from official public datasets.Report a data error.